FDA contradicts Peruvian Health Minister: “Anti-implantation” effect of morning after pill not ruled out
Facebook Twitter Google+ Pinterest Addthis

.- A spokeswoman for the Food and Drug Administration (FDA) has told CNA that the government agency has not ruled out the anti-implantation effect of Levonorgestrel—the generic name for the morning after pill—because it has not received “safety information” to make such a determination. This week Peruvian Minister of Health, Pilar Mazzetti, told reporters the FDA data on the abortion pill is from 2002 and that “recent studies” confirm that the drug’s third mechanism—which is the focal point of the controversy—has been ruled out.

An FDA statement from May 7, 2004, said the morning after pill functions primarily by preventing ovulation, but it can also prevent fertilization, and if fertilization has already taken place, it can prevent the fertilized ovum from implanting itself in the uterus.

This third mechanism is what has caused the controversy in Peru because the Peruvian constitution grants protection to human life from the moment of conception, not implantation.  By denying the anti-implantation effect, Mazzetti is attempting to get around charges that her decision to distribute the drug as part of family planning policy is unconstitutional.

According to Susan Cruzan, public relations specialist of the FDA, the agency’s statement of May 7, 2004, only reiterates that the first mechanism—prevention of ovulation—is the only one that has been confirmed.  The possibility that the drug prevents fertilization and implantation has not been ruled out.

Asked about the recent studies cited by Mazzetti, Cruzan said, “It’s really up to the manufacturer to submit that information to the Food and Drug Administration” because “the manufacturers are the ones that should make the labeling changes.”

“What you can do is call the company and make sure that they have that data and essentially the companies are required to send any new info that is related to the Food and Drug Administration, specifically if it relates to safety information.  So again it’s really up to the manufacturer to submit that information to the food and drug administration and certainly people can call that to our attention,” said Cruzan.

She added that “the way that FDA operates, the FDA will have to see those studies and review them to make a determination based on that.  We make our decisions based on science and the data that is submitted to the agency.”

In addition, Cruzan said that “what would have to happen in order for FDA to change the information that is put out there is that the company would have to submit that data and FDA would then have to update the label.”

“Its a scientific review process,” Cruzan said.  “You can’t just say that, ‘Oh well you heard through us’.  Usually what happens is that it will have to go through the actual manufacturers of those products. You know the manufacturers are the ones that should make the labeling changes.”

Ads by AdsLiveMedia(What's this?)

* The number of messages that can be online is limited. CNA reserves the right to edit messages for content and tone. Comments and opinions expressed by users do not necessarily reflect the opinions or beliefs of CNA. CNA will not publish comments with abusive language, insults or links to other pages


Ads by Google (What's this?)
Ads by Google

Featured Videos

Little Sisters of the Poor press conference in Denver
Little Sisters of the Poor press conference in Denver
Family thrilled to see Pope Francis in Istanbul
Syrian Refugee, Sara, 14, Before Meeting Pope
Ebola orphans thousands of children in West Africa
One year after Haiyan: Philippines rebuilds homes, lives
An Indian contribution to the Vatican's Synod on the Family
Christ Cathedral CNA video Sept 2014
Alejandro Bermudez of CNA accepts ice bucket challenge
'The Real Albania,' remembering those who fled
Pope Francis in Albania, "one of the most important visits of the post-communist era in Albania"
Pope Francis greets paralyzed man who risked all to see him
Franciscans on the banks of the Tiber in Rome, working for the New Evangelization
Pilgrimage from Czech Republic to Assisi and Rome for intentions
Testimony of young Indian who met Pope in Korea
Preparations of the Closing Mass of 6th Asian Youth Day
Missionary of Charity, Korea
Testimony of Christian Love during Pope's Visit to Korea
Religious Sisters in South Korea react to Pope Francis kissing a baby
Warm atmosphere during Holy Mass at Daejeon World Cup Stadium
Images inside Pope Francis flight to South Korea

Liturgical Calendar

December 20, 2014

Advent Weekday

All readings:
Today »
This year »

Catholic Daily

Gospel of the Day

Mt 21:23-27


Daily Readings

First Reading:: Judg 13: 2-7, 24-25A
Gospel:: Lk 1: 5-25

Saint of the Day

St. Romuald »


Homily of the Day

Mt 21:23-27